{"ok":true,"trend":{"id":580306,"platform":"google","region":"SE","key":"wegovy","title":"wegovy","url":"https://trends.google.com/trending?geo=SE&q=wegovy","first_seen":"2026-10-01T07:05:48.296224Z","last_seen":"2026-10-01T11:35:48.751304Z","last_rank":9,"peak_rank":5,"last_volume":1000,"peak_volume":1000,"seen_count":19,"score":0.6475,"category_hint":null,"section":null,"category":null,"summary":"Novo Nordisk is lowering the price of its weight-loss drug Wegovy by 20 percent in Sweden, according to multiple Swedish business and news outlets. The move comes as GLP-1 medicines, once marketed primarily as obesity treatments for patients, are increasingly described in industry coverage as lifestyle drugs competing for customers, intensifying pressure on pricing.","why":"Novo Nordisk's 20% price cut on Wegovy in Sweden signals intensifying competition and market pressure in the weight-loss drug sector","tone":"neutral","entities":["Novo Nordisk","Wegovy","Sweden"],"summarized_at":"2026-10-01T13:09:48.044190Z","meta":{"lang":"sv","picture":"https://encrypted-tbn2.gstatic.com/images?q=tbn:ANd9GcT7k7BlpwiEbb-pyoxjfhCGQNNojyt2DTUql_DIINk78jwgCWqyHYyVW8BOMmQ","traffic":"1000+","published":"Wed, 30 Sep 2026 21:20:00 -0700","picture_source":"Svenska Dagbladet"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Novo Nordisk cuts Wegovy price in Sweden by 20%","timeline":[{"captured_at":"2026-10-01T07:05:48.296224Z","rank":5,"volume":1000},{"captured_at":"2026-10-01T07:20:48.332198Z","rank":5,"volume":1000},{"captured_at":"2026-10-01T07:35:51.429513Z","rank":5,"volume":1000},{"captured_at":"2026-10-01T07:50:48.620336Z","rank":5,"volume":1000},{"captured_at":"2026-10-01T08:05:48.942085Z","rank":6,"volume":1000},{"captured_at":"2026-10-01T08:20:51.648669Z","rank":6,"volume":1000},{"captured_at":"2026-10-01T08:35:50.963149Z","rank":6,"volume":1000},{"captured_at":"2026-10-01T08:50:47.574206Z","rank":6,"volume":1000},{"captured_at":"2026-10-01T09:06:03.007705Z","rank":8,"volume":1000},{"captured_at":"2026-10-01T09:20:59.729788Z","rank":8,"volume":1000},{"captured_at":"2026-10-01T09:35:47.694945Z","rank":8,"volume":1000},{"captured_at":"2026-10-01T09:50:48.284215Z","rank":8,"volume":1000},{"captured_at":"2026-10-01T10:05:47.695479Z","rank":9,"volume":1000},{"captured_at":"2026-10-01T10:20:51.024035Z","rank":9,"volume":1000},{"captured_at":"2026-10-01T10:35:46.995220Z","rank":9,"volume":1000},{"captured_at":"2026-10-01T10:50:46.326186Z","rank":9,"volume":1000},{"captured_at":"2026-10-01T11:05:49.228724Z","rank":9,"volume":1000},{"captured_at":"2026-10-01T11:20:48.922031Z","rank":9,"volume":1000},{"captured_at":"2026-10-01T11:35:48.751304Z","rank":9,"volume":1000}],"posts":[{"platform":"google","url":"https://www.mynewsdesk.com/se/novo-nordisk-scandinavia/pressreleases/novo-saenker-priset-paa-wegovy-r-med-20-procent-3469920","author":"Mynewsdesk","title":"Novo sänker priset på Wegovy® med 20 procent","snippet":null,"posted_at":null,"likes":null},{"platform":"google","url":"https://omni.se/novo-sanker-priset-pa-viktlakemedel-subvention-utreds/a/5pm5L1","author":"Omni – Alla nyheter. Alla perspektiv.","title":"Novo sänker priset på viktläkemedel","snippet":null,"posted_at":null,"likes":null},{"platform":"google","url":"https://www.statnews.com/2026/09/28/glp1-marketing-shift-obesity-medicine-weight-loss-drug/","author":"STAT","title":"Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'","snippet":null,"posted_at":null,"likes":null},{"platform":"google","url":"https://efn.se/novo-kapar-priset-pa-wegovy-i-sverige","author":"EFN","title":"Novo kapar priset på Wegovy i Sverige","snippet":null,"posted_at":null,"likes":null},{"platform":"google","url":"https://www.pharmexec.com/view/daily-peptide-ruling-stalls","author":"Pharmaceutical Executive","title":"Peptide Ruling Stalls | PharmExec","snippet":null,"posted_at":null,"likes":null}],"elsewhere":[],"window":"7d"}}